Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for U9G.066: cancer procoagulant

Summary Distribution Literature Substrates Inhibitors

(Topics flags: A Assay, T Target, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2018
  1. Krause,J. and Frost,C.L.
    In vitro screening of synthetic fluorogenic substrates for detection of cancer procoagulant activity
    Protein J (2018) 37, 151-163. PubMed  Europe PubMed DOI  A
    2. 2015
  2. Kee,N.L., Krause,J., Blatch,G.L., Muramoto,K., Sakka,K., Sakka,M., Naude,R.J., Wagner,L., Wolf,R., Rahfeld,J.U., Demuth,H.U., Mielicki,W.P. and Frost,C.L.
    The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation
    Protein J (2015) 34, 338-348. PubMed  Europe PubMed DOI
    3. 2012
  3. Findeisen,P., Costina,V., Yepes,D., Hofheinz,R. and Neumaier,M.
    Functional protease profiling with reporter peptides in serum specimens of colorectal cancer patients: demonstration of its routine diagnostic applicability
    J Exp Clin Cancer Res (2012) 31, 56-56. PubMed  Europe PubMed DOI
  4. Gordon,S.G. and Mielicki,W.P.
    Cancer procoagulant
    [ISSN:978-0-12-407742-3] (2012) 3, 3749-3752. DOI
  5. Kee,N.L.A., Naude,R.J., Blatch,G.L. and Frost,C.L.
    The effect of cancer procoagulant on expression of metastatic and angiogenic markers in breast cancer and embryonic stem cell lines
    Biol Chem (2012) 393, 113-121. PubMed  Europe PubMed DOI
    6. 2008
  6. Kamocka,M., Pollard,M., Suckow,M., Mielicki,W.P. and Rosen,E.D.
    Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X
    Comp Med (2008) 58, 282-286. PubMed  Europe PubMed  PMC  EPMC
    7. 2006
  7. Kamocka,M., Kaplinska,K. and Mielicki,W.P.
    Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats
    Clin Exp Med (2006) 6, 119-123. PubMed  Europe PubMed DOI  T
  8. Snarska,J., Szajda,S.D., Knas,M., Mroczko,B., Borzym-Kluczyk,M., Kaminski,F., Zwierz,P. and Zwierz,K.
    [Usefulness of detecting cancer procoagulant activity and thyrotropic hormone concentration in the differentiation of tumor-like changes in the thyroid]
    Wiad Lek (2006) 59, 332-335. PubMed  Europe PubMed
    9. 2005
  9. [YEAR:10-5-2005]Kamocka,M., Rozalski,M., Krajewska,U., Wierzbicki,R. and Mielicki,W.P.
    Effect of cancer procoagulant (CP) on the growth and adhesion of MCF-7 cells to vitronectin in vitro
    Cancer Lett (10-5-2005) 222, 89-94. PubMed  Europe PubMed DOI
  10. Kazmierczak,M., Lewandowski,K., Wojtukiewicz,M.Z., Turowiecka,Z., Kolacz,E., Lojko,A., Skrzydlewska,E., Zawilska,K. and Komarnicki,M.
    Cancer procoagulant in patients with adenocarcinomas
    Blood Coagul Fibrinolysis (2005) 16, 543-547. PubMed  Europe PubMed
    11. 2004
  11. Gordon,S.G. and Mielicki,W.P.
    Cancer procoagulant
    [ISSN:0-12-079610-4] (2004) 2, 1405-1408.  V
    12. 2001
  12. Gale,A.J. and Gordon,S.G.
    Update on tumor cell procoagulant factors
    Acta Haematol (2001) 106, 25-32. PubMed  Europe PubMed DOI
  13. Mielicki,W.P.
    Biochemistry of cancer procoagulant
    Haemostasis (2001) 31 Suppl 1, 8-10. PubMed  Europe PubMed
  14. [YEAR:28-8-2001]Olas,B., Wachowicz,B. and Mielicki,W.P.
    Cancer procoagulant and blood platelet activation
    Cancer Lett (28-8-2001) 169, 165-171. PubMed  Europe PubMed DOI
    15. 2000
  15. Ogiichi,T., Hirashima,Y., Nakamura,S., Endo,S., Kurimoto,M. and Takaku,A.
    Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation
    J Neurooncol (2000) 46, 1-9. PubMed  Europe PubMed DOI
  16. [YEAR:1-2-2000]Olas,B., Wachowicz,B., Mielicki,W.P. and Buczynski,A.
    Free radicals are involved in cancer procoagulant-induced platelet activation
    Thromb Res (1-2-2000) 97, 169-175. PubMed  Europe PubMed DOI
    17. 1999
  17. [YEAR:1-11-1999]Mielicki,W.P., Tenderenda,M., Rutkowski,P. and Chojnowski,K.
    Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients
    Cancer Lett (1-11-1999) 146, 61-66. PubMed  Europe PubMed DOI
    18. 1998
  18. [YEAR:1-7-1998]Falanga,A., Consonni,R., Marchetti,M., Locatelli,G., Garattini,E., Passerini,C.G., Gordon,S.G. and Barbui,T.
    Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells
    Blood (1-7-1998) 92, 143-151. PubMed  Europe PubMed
    19. 1997
  19. Mielicki,W.P., Mielicka,E. and Gordon,S.G.
    Cancer procoagulant activity studies using synthetic peptidyl substrates
    Thromb Res (1997) 87, 251-256. PubMed  Europe PubMed DOI
    20. 1994
  20. Gordon,S.G.
    Cancer procoagulant
    Methods Enzymol (1994) 244, 568-583. PubMed  Europe PubMed DOI  V
    21. 1993
  21. Mielicki,W.P. and Gordon,S.G.
    Three-stage chromogenic assay for the analysis of activation properties of factor X by cancer procoagulant
    Blood Coagul Fibrinolysis (1993) 4, 441-446. PubMed  Europe PubMed
    22. 1992
  22. [YEAR:30-4-1992]Moore,W.R.
    The purification and properties of cancer procoagulant from murine tumors
    Biochem Biophys Res Commun (30-4-1992) 184, 819-824. PubMed  Europe PubMed DOI
    23. 1991
  23. Gordon,S.G. and Mourad,A.M.
    The site of activation of factor X by cancer procoagulant
    Blood Coagul Fibrinolysis (1991) 2, 735-739. PubMed  Europe PubMed
    24. 1990
  24. Alessio,M.G., Falanga,A., Consonni,R., Bassan,R., Minetti,B., Donati,M.B. and Barbui,T.
    Cancer procoagulant in acute lymphoblastic leukemia
    Eur J Haematol (1990) 45, 78-81. PubMed  Europe PubMed
  25. [YEAR:13-8-1990]Donati,M.B., Falanga,A., Consonni,R., Alessio,M.G., Bassan,R., Buelli,M., Borin,L., Catani,L., Pogliani,E. and Gugliotta,L.
    Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity
    Thromb Haemost (13-8-1990) 64, 11-16. PubMed  Europe PubMed
  26. [YEAR:1-10-1990]Gordon,S.G. and Cross,B.A.
    An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker
    Cancer Res (1-10-1990) 50, 6229-6234. PubMed  Europe PubMed
    27. 1989
  27. Falanga,A., Shaw,E., Donati,M.B., Consonni,R., Barbui,T. and Gordon,S.
    Inhibition of cancer procoagulant by peptidyl diazomethyl ketones and peptidyl sulfonium salts
    Thromb Res (1989) 54, 389-398. PubMed  Europe PubMed  I
    28. 1988
  28. Falanga,A., Alessio,M.G., Donati,M.B. and Barbui,T.
    A new procoagulant in acute leukemia
    Blood (1988) 71, 870-875. PubMed  Europe PubMed
    29. 1987
  29. Falanga,A., Bolognese Dalessandro,A.P., Casali,B., Roncaglioni,M.C. and Donati,M.B.
    Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics
    Int J Cancer (1987) 39, 774-777. PubMed  Europe PubMed
    30. 1986
  30. Donati,M.B., Gambacorti-Passerini,C., Casali,B., Falanga,A., Vannotti,P., Fossati,G., Semeraro,N. and Gordon,S.G.
    Cancer procoagulant in human tumor cells: evidence from melanoma patients
    Cancer Res (1986) 46, 6471-6474. PubMed  Europe PubMed
    31. 1985
  31. Falanga,A. and Gordon,S.G.
    Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue
    Biochemistry (1985) 24, 5558-5567. PubMed  Europe PubMed
    32. 1981
  32. [YEAR:1-11-1981]Delaini,F., Colucci,M., de Bellis Vitti,G., Locati,D., Poggi,A., Semeraro,N. and Donati,M.B.
    Cancer cell procoagulant: a novel vitamin K-dependent activity
    Thromb Res (1-11-1981) 24, 263-266. PubMed  Europe PubMed
  33. Gordon,S.G. and Cross,B.A.
    A factor X-activating cysteine protease from malignant tissue
    J Clin Invest (1981) 67, 1665-1671. PubMed  Europe PubMed  PMC  EPMC
    34. 1980
  34. [YEAR:1-5-1980]Colucci,M., Curatolo,L., Donati,M.B. and Semeraro,N.
    Cancer cell procoagulant activity: evaluation by an amidolytic assay
    Thromb Res (1-5-1980) 18, 589-595. PubMed  Europe PubMed
  35. Hilgard,P. and Whur,P.
    Factor X-activating activity from Lewis lung carcinoma
    Br J Cancer (1980) 41, 642-643. PubMed  Europe PubMed  PMC  EPMC
    36. 1979
  36. Curatolo,L., Colucci,M., Cambini,A.L., Poggi,A., Morasca,L., Donati,M.B. and Semeraro,N.
    Evidence that cells from experimental tumours can activate coagulation factor X
    Br J Cancer (1979) 40, 228-233. PubMed  Europe PubMed  PMC  EPMC
    37. 1975
  37. Gordon,S.G., Franks,J.J. and Lewis,B.
    Cancer procoagulant A: a factor X activating procoagulant from malignant tissue
    Thromb Res (1975) 6, 127-137. PubMed  Europe PubMed

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2026 EBI
Terms of use